Review Article
Diagnosis and Management of Peritoneal Metastases from Ovarian Cancer
Table 3
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer.
| Author | Year | N | OS | (months) | PFS | (months) | | | | Median | Mean | Median | Mean |
| Deraco et al. [97] | 2001 | 27 | | | 21.8 | | Zanon et al. [98] | 2004 | 30 | 28.1 | | | | Raspagliesi et al. [99] | 2006 | 40 | | 41.4 | | 23.9 | Helm et al. [100] | 2007 | 18 | 31 | | 10 | | Di Giorgio et al. [101] | 2008 | 25 | 22.5 | | 15.5 | | Fagotti et al. [102] | 2009 | 25 | | | 10 | | Carrabin et al. [103] | 2010 | 8 | | | 10 | | Spiliotis et al. [86] | 2011 | 25 | 19.5 | | 14.5 | |
|
|
OS: overall survival; PFS: progression-free survival.
|